Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial disease

Journal of General Internal Medicine

Volumn 21, Issue 7, 2006, Pages 711-714

  Banta, Meggan R ^a   Ma, Fangchao ^a   Bravata, Dawn M ^b   Kirsner, Robert S ^a   Federman, Daniel G ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Hyperlipidemia; Peripheral arterial disease

Indexed keywords

ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; AGING; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; STROKE; UNIVARIATE ANALYSIS; VETERAN;

AGED; ANALYSIS OF VARIANCE; ANTILIPEMIC AGENTS; ARTERIAL OCCLUSIVE DISEASES; CHOLESTEROL, LDL; FLORIDA; HUMANS; LIPIDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33745675488     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2006.00456.x     Document Type: Article

References (21)

1. American Cancer Society. Cancer Facts and Figures 2000. Available at: http://www.cancer.org/docroot/stt/content/stt_lx_2000_facts_and _figures.asp. Accessed 2004.
2. Kempczinski RF, Bernhard VM. Introduction and general considerations [section VIII, management of chronic lower limb ischaemia]. In: Rutherford RB, ed. Vascular Surgery. 3rd ed. Philadelphia, PA: WB Saunders; 1989:643-52.
3. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94:3026-49.
4. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6.
5. Rockson SG, Cooke JP. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. Adv Inter Med. 1998;43:253-77.
6. Orchard TJ, Strandness DE. Assessment of peripheral vascular disease in diabetes - report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association. Circulation. 1993;88:819-28.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-97.
8. Grundy SM, Cleeman JI, Merz B, Brewer HB. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110:227-39.
9. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:7-22.
10. Leng GC, Price JF, Jepson RG. Lipid-Lowering for Lower Limb Atherosclerosis. The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons; 2004. Available at: http://212.49.218.202/abstracts/ab000123. htm.
11. Mc Dermott MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively modified in peripheral arterial disease than in coronary artery disease. J Gen Intern Med. 1997;12:209-15.
12. Anand SS, Kundi A, Eikelboom J, Yusuf S. Low rates of preventive practices in patients with peripheral vascular disease. Can J Cardiol. 1999;15:1259-63.
13. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1380-1.
14. Rehring TF, Sandhoff BG, Stolcpart RS, Merenich JA, Hollis HW Jr. Atherosclerotic risk factor contol in patients with peripheral arterial disease. J Vasc Surg. 2005;41:816-22.
15. Okaa RK, Umoh E, Szuba A, Giacomini JC, Cooke JP. Suboptimal intensity of risk factor modification in PAD. Vasc Med. 2005;10:91-6.
16. Federman DG, Bravata D, Ranani D, Kirsner RS. Peripheral vascular diseas: are current guidelines being met? Mayo Clin Proc. 2005;80:494-8.
17. Nass CM, Allen JK, Jermyn RM, et al. Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease. Vasc Med. 2001;6:35-41.
18. Cote M, Ligetti R, Cutler B, Nelson P. Management of hyperlipidemia in patients with vascular disease. J Vasc Nurs. 2003;21:63-7.
19. Anand SS, Kundl A, Eikelboom J, Yusuf S. Low rates of preventive practices in patients with peripheral vascular disease. Can J Cardiol. 1999;15:1259-63.
20. Clark AL, Byrne JC, Nasser A, Mc Groarty, Kennedy JA. Cholesterol in peripheral vascular disease-a suitable case for treatment? QJ Med. 1999;92:219-22.
21. Mc Kenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119-28.